Covalent FAPI PET enables accurate management of medullary thyroid carcinoma: A prospective single-arm comparative clinical trial.
Ziren Kong(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaoyan Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mengxin Xu(Peking University), Xi‐Yang Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Changming An(Chinese Academy of Medical Sciences & Peking Union Medical College), Tianyu Men(Peking University), Chen Liu(Novartis (Switzerland)), Nan Li(Peking University Cancer Hospital), Yang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Song Ni(Chinese Academy of Medical Sciences & Peking Union Medical College), Junyi Chen(Peking University), Zhibo Liu(First Affiliated Hospital of Zhengzhou University), Xiao‐Wei Fan(Beijing Tsinghua Chang Gung Hospital), Zhi Yang(Peking University), Li Zhu(Peking University), Jian Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiazhao Huang, Yansong Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Yiming Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinfeng Lin(Peking University)
Cited by 1
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k